Loading...
Loading...
Cytokinetics, Incorporated
CYTK, announced today that NASDAQ has approved the Company's request
to voluntarily transfer the listing of its shares of common stock from The
NASDAQ Global Market to The NASDAQ Capital Market. The transfer will be
effective at the opening of business on December 20, 2012 and the Company's
common stock will continue to trade under the symbol "CYTK".
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in